ImmunityBio, Inc. (IBRX)

CIK 1326110 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ImmunityBio, Inc..

Recent SEC filings

FiledFormAccession number
Aug 6, 2026SCHEDULE 13D/A0001193125-26-338651
Aug 4, 20268-K0001326110-26-000077
Aug 4, 202610-Q0001326110-26-000079
Jul 30, 20268-K0001326110-26-000071
Jul 6, 202640001849739-26-000014
Jul 6, 202640001529371-26-000008
Jul 2, 20261440001950047-26-006831
Jul 1, 202640001849739-26-000011
Jul 1, 20261440001950047-26-006714
Jun 30, 20261440001950047-26-006655
Jun 29, 20261440001950047-26-006608
Jun 26, 202640001647994-26-000011
Jun 10, 202640001849739-26-000007
Jun 10, 202640001371407-26-000003
Jun 10, 202640001529371-26-000003
Jun 10, 202640001349193-26-000003
Jun 10, 202640001822674-26-000003
Jun 10, 20268-K0001326110-26-000064
Jun 10, 202640001364846-26-000003
Jun 5, 202640001647994-26-000008
Jun 4, 20261440001949846-26-000345
May 18, 20268-K0001193125-26-229153
May 7, 20268-K0001326110-26-000057
May 7, 202610-Q0001326110-26-000059
Apr 30, 2026ARS0001326110-26-000048